BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29102599)

  • 1. Differential effects of lipid biosynthesis inhibitors on Zika and Semliki Forest viruses.
    Royle J; Donald CL; Merits A; Kohl A; Varjak M
    Vet J; 2017 Dec; 230():62-64. PubMed ID: 29102599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the Host Cell Lipid Metabolism Induced by Hypolipidemic Drugs Targeting the Acetyl Coenzyme A Carboxylase Impairs West Nile Virus Replication.
    Merino-Ramos T; Vázquez-Calvo Á; Casas J; Sobrino F; Saiz JC; Martín-Acebes MA
    Antimicrob Agents Chemother; 2016 Jan; 60(1):307-15. PubMed ID: 26503654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-
    Merino-Ramos T; Jiménez de Oya N; Saiz JC; Martín-Acebes MA
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Activity of Compound L3 against Dengue and Zika Viruses In Vitro and In Vivo.
    Chuang FK; Liao CL; Hu MK; Chiu YL; Lee AR; Huang SM; Chiu YL; Tsai PL; Su BC; Chang TH; Lin CC; Shih CC; Yen LC
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
    Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
    J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of Semliki Forest virus RNA requires continuous lipid synthesis.
    Perez L; Guinea R; Carrasco L
    Virology; 1991 Jul; 183(1):74-82. PubMed ID: 1647077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Inhibitors of ZIKV Replication.
    Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis and Discovery of N,N'-Carbazoyl-aryl-urea Inhibitors of Zika NS5 Methyltransferase and Virus Replication.
    Spizzichino S; Mattedi G; Lauder K; Valle C; Aouadi W; Canard B; Decroly E; Kaptein SJF; Neyts J; Graham C; Sule Z; Barlow DJ; Silvestri R; Castagnolo D
    ChemMedChem; 2020 Feb; 15(4):385-390. PubMed ID: 31805205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.
    Raini SK; Takamatsu Y; Dumre SP; Urata S; Mizukami S; Moi ML; Hayasaka D; Inoue S; Morita K; Ngwe Tun MM
    Antiviral Res; 2021 Aug; 192():105121. PubMed ID: 34175321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.
    Cai L; Sun Y; Song Y; Xu L; Bei Z; Zhang D; Dou Y; Wang H
    Arch Virol; 2017 Sep; 162(9):2847-2853. PubMed ID: 28597088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.
    Quintana VM; Selisko B; Brunetti JE; Eydoux C; Guillemot JC; Canard B; Damonte EB; Julander JG; Castilla V
    Antiviral Res; 2020 Apr; 176():104749. PubMed ID: 32081740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments.
    Varghese FS; Rausalu K; Hakanen M; Saul S; Kümmerer BM; Susi P; Merits A; Ahola T
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Zika Virus Replication by Silvestrol.
    Elgner F; Sabino C; Basic M; Ploen D; Grünweller A; Hildt E
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29584632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms.
    Lai ZZ; Ho YJ; Lu JW
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32906689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
    Adcock RS; Chu YK; Golden JE; Chung DH
    Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
    Vicenti I; Boccuto A; Giannini A; Dragoni F; Saladini F; Zazzi M
    Virus Res; 2018 Jan; 244():64-70. PubMed ID: 29113824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
    Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Analysis of African and Asian Lineage-Derived Zika Virus Strains Reveals Differences in Activation of and Sensitivity to Antiviral Innate Immunity.
    Esser-Nobis K; Aarreberg LD; Roby JA; Fairgrieve MR; Green R; Gale M
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.
    Panayiotou C; Lindqvist R; Kurhade C; Vonderstein K; Pasto J; Edlund K; Upadhyay AS; Överby AK
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis.
    Yang CF; Gopula B; Liang JJ; Li JK; Chen SY; Lee YL; Chen CS; Lin YL
    Emerg Microbes Infect; 2018 Nov; 7(1):187. PubMed ID: 30459406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.